Here's Why Shareholders May Want To Be Cautious With Increasing Kamada Ltd.'s (TLV:KMDA) CEO Pay Packet
Dec 05
Have your own idea? Try our Stock Screener
Israeli (TA) Biotech Industry Analysis
UpdatedDec 19, 2024
DataAggregated Company Financials
Companies14
- 7D-3.4%
- 3M-11.0%
- 1Y-26.4%
- YTD-27.8%
The Biotech industry is down 6.0% over the last week with Kamada the worst performer, down 1.5%. In contrast, Matricelf has gained 5.7%. Overall the industry is down 27% in 12 months. Looking forward, earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 19 Dec 2024 | ₪1.9b | ₪682.8m | -₪225,737,632.40 | 13.6x | -8.3x | 2.7x |
| Sat, 16 Nov 2024 | ₪2.1b | ₪700.2m | -₪255,373,146.50 | 13.6x | -8.2x | 3x |
| Mon, 14 Oct 2024 | ₪2.0b | ₪689.6m | -₪258,640,591.70 | 13x | -7.7x | 2.9x |
| Wed, 11 Sep 2024 | ₪2.1b | ₪689.0m | -₪258,135,025.50 | 13.1x | -8x | 3x |
| Fri, 09 Aug 2024 | ₪2.1b | ₪650.8m | -₪333,570,086.80 | 16.6x | -6.2x | 3.2x |
| Sun, 07 Jul 2024 | ₪2.1b | ₪635.4m | -₪327,607,899.50 | 16.5x | -6.3x | 3.3x |
| Tue, 04 Jun 2024 | ₪2.1b | ₪628.5m | -₪327,084,835.30 | 16x | -6.4x | 3.3x |
| Thu, 02 May 2024 | ₪2.1b | ₪579.6m | -₪408,234,408.10 | 22.3x | -5.2x | 3.7x |
| Sat, 30 Mar 2024 | ₪2.3b | ₪571.9m | -₪387,758,675.20 | 23.2x | -6x | 4.1x |
| Mon, 26 Feb 2024 | ₪2.5b | ₪578.1m | -₪363,630,415.40 | 63x | -6.8x | 4.3x |
| Wed, 24 Jan 2024 | ₪2.4b | ₪642.1m | -₪405,745,702.00 | 61.1x | -5.8x | 3.7x |
| Fri, 22 Dec 2023 | ₪2.4b | ₪620.9m | -₪396,547,626.00 | 62.3x | -6x | 3.8x |
| Sun, 19 Nov 2023 | ₪2.1b | ₪635.7m | -₪381,920,969.00 | 57.5x | -5.6x | 3.3x |
| Tue, 17 Oct 2023 | ₪2.1b | ₪644.4m | -₪425,239,434.00 | 74.4x | -5x | 3.3x |
| Thu, 14 Sep 2023 | ₪2.2b | ₪621.8m | -₪381,612,902.00 | 70.6x | -5.9x | 3.6x |
| Sat, 12 Aug 2023 | ₪1.9b | ₪553.4m | -₪394,409,361.00 | 60.3x | -4.8x | 3.4x |
| Mon, 10 Jul 2023 | ₪1.9b | ₪547.5m | -₪395,034,706.00 | n/a | -4.8x | 3.5x |
| Wed, 07 Jun 2023 | ₪1.9b | ₪545.3m | -₪401,711,047.00 | n/a | -4.6x | 3.4x |
| Fri, 05 May 2023 | ₪1.7b | ₪530.6m | -₪366,905,867.00 | n/a | -4.7x | 3.2x |
| Sun, 02 Apr 2023 | ₪1.6b | ₪606.9m | -₪422,957,850.00 | 2.3x | -3.8x | 2.6x |
| Tue, 28 Feb 2023 | ₪1.6b | ₪563.6m | -₪481,731,309.00 | 4.6x | -3.3x | 2.8x |
| Thu, 26 Jan 2023 | ₪1.6b | ₪517.9m | -₪464,719,764.00 | 17.2x | -3.4x | 3.1x |
| Sat, 24 Dec 2022 | ₪1.5b | ₪533.0m | -₪474,652,315.00 | 17.3x | -3.2x | 2.9x |
| Mon, 21 Nov 2022 | ₪1.7b | ₪486.4m | -₪485,922,188.00 | 18.5x | -3.5x | 3.5x |
| Wed, 19 Oct 2022 | ₪1.8b | ₪493.5m | -₪487,265,763.00 | 18.3x | -3.8x | 3.7x |
| Fri, 16 Sep 2022 | ₪2.1b | ₪486.3m | -₪429,178,480.00 | 9x | -4.8x | 4.2x |
| Sun, 14 Aug 2022 | ₪2.2b | ₪470.6m | -₪385,585,689.00 | 13x | -5.8x | 4.8x |
| Tue, 12 Jul 2022 | ₪2.1b | ₪496.6m | -₪403,051,429.00 | 12.7x | -5.3x | 4.3x |
| Thu, 09 Jun 2022 | ₪2.2b | ₪477.6m | -₪394,037,152.00 | 12.6x | -5.6x | 4.6x |
| Sat, 07 May 2022 | ₪2.7b | ₪479.4m | -₪508,635,352.00 | 14.1x | -5.2x | 5.5x |
| Mon, 04 Apr 2022 | ₪2.8b | ₪542.7m | -₪397,839,495.00 | 10.4x | -7.1x | 5.2x |
| Wed, 02 Mar 2022 | ₪2.7b | ₪460.2m | -₪222,599,145.00 | 7x | -12.2x | 5.9x |
| Fri, 28 Jan 2022 | ₪3.1b | ₪456.6m | -₪220,087,085.00 | 6.9x | -14.2x | 6.9x |
| Sun, 26 Dec 2021 | ₪3.7b | ₪438.3m | -₪214,461,220.00 | 9.6x | -17.2x | 8.4x |
Price to Earnings Ratio
-17.2x
Current Industry PE
- Investors are pessimistic on the Israeli Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.9x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
- Losses for companies in the Biotechs industry have mostly stayed the same over the last three years.
- Meanwhile revenues for these companies have grown 16% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, losses haven't seen much improvement.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 0.24% | |
| Healthcare | -0.94% | |
| Biotech | -3.39% | |
| Biotech | -3.39% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MTLF Matricelf | ₪3.82 | 5.7% +₪3.3m | -6.8% | n/a | |
| CBI Clal Biotechnology Industries | ₪0.36 | 2.0% +₪1.1m | -12.1% | PS1744.9x | |
| PLNT PlantArc Bio | ₪2.35 | 11.9% +₪832.3k | -32.4% | PS1.6x |
